Endophthalmitis caused by Pseudomonas aeruginosa after phakic posterior chamber intraocular lens implantation to correct high myopia.
Oum
Boo Sup
BS
Lee
Jong Soo
JS
Choi
Hee Young
HY
Lee
Ji Eun
JE
Kim
Soo Jin
SJ
Lee
Ji-Eun
JE
D002442:Ceftazidime / Q000627:therapeutic use; D003519:Cyclopentolate / Q000627:therapeutic use; D020878:Device Removal; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular; D047728:Myopia, Degenerative / Q000601:surgery*; D054120:Phakic Intraocular Lenses; D057972:Posterior Eye Segment / Q000601:surgery; D011183:Postoperative Complications; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D014640:Vancomycin / Q000627:therapeutic use; D014792:Visual Acuity; D014821:Vitrectomy; D055815:Young Adult
D014640:Vancomycin; D003907:Dexamethasone; D002442:Ceftazidime; D003519:Cyclopentolate